The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD), Uptravi for injection, 1,800 mcg/vial, of Actelion Pharmaceuticals US, Inc. (Actelion).
from Health News | Latest Healthcare Sector & Healthcare Industry news, Information and Updates: ET HealthWorld : ETHealthworld.com https://ift.tt/NX5HCVl
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment